ArticleDigital health
A multi-patch-based deep learning model with VGG19 for breast cancer classifications in the pathology images.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Diagnostic Performance and Geographic Variation in Mammography Services: A Nine-Year Audit from Southern Jordan.Diagnostics (Basel, Switzerland) · 2026Article
- AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy.European urology oncology · 2026Article
- Interpretable deep learning for rotator cuff calcific tendinopathy diagnosis: a multi-center study.Scientific reports · 2026Article
- Explainable Breast Cancer Detection Using Hierarchical Multi-Scale and Edge-Aware Transformer Networks.Bioengineering (Basel, Switzerland) · 2026Article
- Transformer based breast cancer classification from histopathological images using sequential residual recurrent multiscale attention network.Scientific reports · 2026Article
- LBNet: an optimized lightweight CNN for mammographic breast cancer classification with XAI-based interpretability.Scientific reports · 2025Article
- Breast cancer diagnosis from histopathological images and molecular signatures by fusing features with an explainable AI-based residual tabular network model.Journal of computer-aided molecular design · 2025Article
- Systematic evaluation of tools used for single-cell mCommunications biology · 2025Article
- Advanced object detection for smart accessibility: a Yolov10 with marine predator algorithm to aid visually challenged people.Scientific reports · 2025Article
- Advanced internet of things enhanced activity recognition for disability people using deep learning model with nature-inspired optimization algorithms.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Breast cancer encompasses various subtypes with distinct prognoses, necessitating accurate stratification methods. Current techniques rely on quantifying gene expression in limited subsets. Given the complexity of breast tissues, effective detection and classification of breast cancer is crucial in medical imaging. This study introduces a novel method, MPa-DCAE, which uses a multi-patch-based deep convolutional auto-encoder (DCAE) framework combined with VGG19 to detect and classify breast cancer in histopathology images. Methods: The proposed MPa-DCAE model leverages the hierarchical feature extraction capabilities of VGG19 within a DCAE framework, designed to capture intricate patterns in histopathology images. By using a multi-patch approach, regions of interest are extracted from pathology images to facilitate localized feature learning, enhancing the model's discriminatory power. The auto-encoder component enables unsupervised feature learning, increasing resilience and adaptability to variations in image features. Experiments were conducted at various magnifications on the CBIS-DDSM and MIAS datasets to validate model performance. Results: Experimental results demonstrated that the MPa-DCAE model outperformed existing methods. For the CBIS-DDSM dataset, the model achieved a precision of 97.96%, a recall of 94.85%, and an accuracy of 98.36%. For the MIAS dataset, it achieved a precision of 97.99%, a recall of 97.2%, and an accuracy of 98.95%. These results highlight the model's robustness and potential for clinical application in computer-assisted diagnosis. Conclusion: The MPa-DCAE model, integrating VGG19 and DCAE, proves to be an effective, automated approach for diagnosing breast cancer. Its high accuracy and generalizability make it a promising tool for clinical practice, potentially improving patient care in histopathology-based breast cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.